A Caltech researcher who shared the 2018 Nobel Prize in Chemistry has retracted a 2019 paper after being unable to replicate the results.
Frances Arnold, who won half of the 2018 prize for her work on the evolution of enzymes, tweeted the news earlier today:
A team of researchers in Saudi Arabia, led by an ex-pat from Johns Hopkins University, has lost three papers for problems with the images in their articles.
The three retractions pushed the journal — which has become a “major retraction engine” for reasons we explain here and here — over 100 for 2019.
In December, PLOS ONE retrcated three papers by the group, led by Michael DeNiro, of the King Khaled Eye Specialist Hospital in Riyadh. First, the journal retracted a 2011 article, “Inhibition of reactive gliosis prevents neovascular growth in the mouse model of oxygen-induced retinopathy,” the co-authors were Falah H Al-Mohanna and Futwan A Al-Mohanna. According to the retraction notice:
Continue reading PLOS ONE retracts a paper first flagged in 2015 — and breaks the 100 retraction barrier for 2019
In August 2020, Retraction Watch will turn 10 — a milestone we still can’t quite wrap our minds around. When we started the blog in 2010, we thought we might have enough material for a post or two a month. Little did we know that our little side gig would eventually lead to the world’s largest database of retracted papers; or that there would be so many of them (now more than 1,400 per year); or, to be honest, how little we (and others) knew about these events.
This year saw several important developments for our project. We entered into a partnership with Zotero that allows them to alert users to retractions of any papers in their personal libraries — and, we hope, helps researchers to better avoid citing retracted papers in their work. Our database now includes more than 20,000 retractions.
Continue reading A look back at Retraction Watch in 2019 — and forward to our 10th anniversary
Retraction Watch readers may recall the name Alexander Neumeister.
In 2016, The New York Times reported on his dismissal from the New York University School of Medicine following claims of misconduct in a trial Neumeister was running.
A lot has happened in the case since, including embezzlement charges for which he pleaded guilty. Now, the U.S. Office of Research Integrity has found that Neumeister also committed research misconduct.
Continue reading Psychiatrist who stole grant funds also engaged in research misconduct, says ORI
A team of physicists in India has notched their third retraction for problematic images and other issues that also have prompted at least four corrections of their work.
The authors, Sk. Shahenoor Basha, of the Solid State Ionics Laboratory at KL University in Guntur, and M.C. Rao, of Andhra Loyola College in Vijayawada, have lost a 2018 article in the International Journal of Polymer Science titled ““Spectroscopic and electrochemical properties of [PVA/PVP]:[MgCl2{6H2O}] blend polymer electrolyte films.”
According to the retraction notice:
Continue reading ‘A satisfactory explanation was not provided’: Physicists in India lose third paper
Before we present this week’s Weekend Reads — the last of 2019! — a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.
The week at Retraction Watch featured:
Here’s what was happening elsewhere:
Continue reading Weekend reads: How to be a statistical detective; a $5.5 million settlement over hidden grants; 15 studies that challenged medical dogma
We’ve seen authors fake peer review by creating fake email addresses, and even companies that use photos of celebrities to lure unsuspecting authors. Now along comes a new scam, this one involving special issues of journals. In “Predatory publishing, hijacking of legitimate journals and impersonation of researchers via special issue announcements: a warning for editors and authors about a new scam,” Jamie Trapp, of Queensland University of Technology, describes what happened when scammers tried to snare the journal he edits — Australasian Physical & Engineering Sciences in Medicine. We asked Trapp to answer a few questions about the scheme.
Retraction Watch (RW): You recently wrote about what you call “a new scam.” Tell us about this scam.
Continue reading ‘Disbelief’: Researchers, watch out for this new scam involving journal special issues
The Images in Clinical Medicine section of the New England Journal of Medicine (NEJM) is prime real estate for physicians and others wanting to share a compelling picture with their colleagues. But earlier this month, an eye specialist in Michigan saw double when he looked at the Dec. 5, 2019, installment of the feature.
Depicted was a picture from a pair of eye specialists in India who claimed to have seen a case of a person who’d suffered retinal bleeding after having been struck in the eye by a tennis ball:
Continue reading How a plagiarized eye image in the NEJM was discovered
Journal stings come in various shapes and sizes. There are the hilarious ones in which authors manage to get papers based on Seinfeld or Star Wars published. There are those that play a role in the culture wars. And then there are some on a massive scale, with statistical analyses.
That’s how we’d describe the latest paper by Ottawa journalologists Kelly Cobey, David Moher and colleagues. We asked Cobey and Moher to answer some questions about the recently posted preprint, “Stress testing journals: a quasi-experimental study of rejection rates of a previously published paper.”
Retraction Watch (RW): What prompted you to do this study?
Continue reading A ‘stress test’ for journals: What happened when authors tried to republish a Nature paper more than 600 times?
Hueng-Sik Choi, a researcher at Chonnam National University in Gwangju in South Korea, is up to four retractions for image manipulation.
The latest retraction for Choi, for a 2006 paper titled “Orphan nuclear receptor Nur77 induces zinc finger protein GIOT-1 gene expression, and GIOT-1 acts as a novel corepressor of orphan nuclear receptor SF-1 via recruitment of HDAC2,” appeared in the Journal of Biological Chemistry (JBC) earlier this month:
Continue reading Endocrinology researcher in South Korea scores four retractions in a year.jpg){kind=link}
